Sat.Jan 04, 2020 - Fri.Jan 10, 2020

article thumbnail

VirTrial Wins Digital Health Solutions Category in the Fierce Innovation Awards – LifeSciences Edition 2019

VirTrial

Scottsdale, AZ (January 9, 2020) – VirTrial announced today that it has been selected as a winner in this year’s Fierce Innovation Awards – LifeSciences Edition, a peer reviewed awards program from the publisher of FierceBiotech and FiercePharma. The competition highlights companies that demonstrated innovative solutions, technologies, and services that have the potential to make the greatest impact for biotech and pharma companies.

article thumbnail

Can you trust Turkey-approved Alipza? Is it the same as U.S.-Approved Livalo?

Pharmacy Checkers

This post is mostly a story about a very well manufactured, safe and effective, foreign version of an FDA-approved drug. These drugs are normally far less expensive than the FDA-approved version sold in the U.S. and arguably just as safe. The FDA can prevent the importation of such drugs – but the agency is actually encouraged by law not to do so if the import is for personal use only.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Predicting the Structure of Proteins: Why It Matters

Pharma Focus Asia

After water, protein is the next most abundant substance found in the human body. In fact, some experts predict that the human body produces anywhere between 20,000 and 100,000 different types of proteins. That doesn’t include all of the various proteins found in our food sources, biopharmaceuticals, and those produced by other living organisms around […].

Protein 52
article thumbnail

Enterprise Therapeutics publishes paper on novel therapeutic approach for treatment of all cystic fibrosis patients

Drug Discovery Today

“TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis” published in American Journal of Respiratory and Critical Care Medicine.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Eli Lilly and Company in Collaboration with Strateos, Inc. Launch Remote-Controlled Robotic Cloud Lab

Drug Discovery Today

Web-based platform provides broad access to the first-ever cloud laboratory to integrate automated biology and chemistry research capabilities in a closed-loop system that enables an accelerated design-make-test-analyze cycle

article thumbnail

Scientists receive research funding from FDA to use advanced tools for assessment of drug delivery to the skin

Drug Discovery Today

Collaboration of researchers will improve imaging methods to assess extent of drug delivery to the skin – including creams and lotions for conditions like eczema

More Trending

article thumbnail

£1 million project launch to monitor ex-footballers for early signs of dementia

Drug Discovery Today

Researchers at the University of East Anglia are crowd-funding a new project to test former professional football players for early signs of dementia.

article thumbnail

Section 804’s Conflicting Standards for Personal vs. Wholesale Drug Importation and Why it Matters

Pharmacy Checkers

The FDA has drafted a proposed rule to facilitate wholesale importation of lower-cost drugs from Canada, pursuant to Section 804 of the Food, Drug and Cosmetic Act. Importation from Canada is legal under this section of U.S. law, but only if the Secretary of Health and Human Services (HHS) certifies, as stated in Part L , that such importation would pose “no additional risk” to the public and would help save the American consumer money.

Drugs 58